Daily melatonin administration attenuates age-dependent disturbances of cardiovascular rhythms

Current Aging Science

Volumn 9, Issue 1, 2016, Pages 5-13

  Gubin, Denis G ^a   Gubin, Gennady D ^a   Gapon, Ludmila I ^b   Weinert, Dietmar ^c  

^a TYUMEN STATE MEDICAL UNIVERSITY   (Russian Federation)

^b INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Aging; Circadian rhythms; Diastolic blood pressure; Heart rate; Hypertension; Melatonin; Systolic blood pressure

Indexed keywords

MELATONIN; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART ARRHYTHMIA; HEART RATE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; SLEEP WAKING CYCLE; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; BLOOD PRESSURE; CIRCADIAN RHYTHM; DRUG EFFECTS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; BLOOD PRESSURE; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; RISK FACTORS;

EID: 84959338537     PISSN: 18746098     EISSN: 18746128     Source Type: Journal    
DOI: 10.2174/1874609809666151130220011     Document Type: Article

References (73)

1. Bild DE, Fitzpatrick A, Fried LP, et al. Age-related trends in car-diovascular morbidity and physical functioning in the elderly: The cardiovascular health study. J Am Geriatr Soc 1993; 41(10): 1047-56.
2. O'Sullivan C, Duggan J, Atkins N, O'Brien E. Twenty-four-hourambulatory blood pressure in community-dwelling elderly men and women, aged 60-102 years. J Hypertens 2003; 21(9): 1641-7.
3. Trenkwalder P, Ruland D, Stender M, et al. Prevalence, awareness,treatment and control of hypertension in a population over the age of 65 years: Results from the Starnberg study on epidemiology of Parkinsonism and Hypertension in the elderly (STEPHY). J Hypertens 1994; 12(6): 709-16.
4. Gubin D, Cornelissen G, Halberg F, Gubin G, Uezono K, Kawa-saki T. The human blood pressure chronome: A biological gauge of aging. In Vivo 1997; 11(6): 485-94.
5. Gubin DG, Gubin GD. Some general effects of aging upon cir-cadian parameters of cardiovascular ariables assessed longitudinally by ambulatory monitoring. Chronobiol Int 2001; 18: 1106-7.
6. Gubin DG, Gubin GD, Komarov PI. Aging viewed through theprism of temporal order of living systems In Russian. Uspehi Gerontologii (Adv Gerontol) 1998; 2: 67-73.
7. Ikonomov O, Stoynev G, Cornelissen G, et al. The blood pressureand heart rate chronome of centenarians. Chronobiologia 1991; 18(4): 167-79.
8. Otsuka K, Watanabe H, Cornelissen G, et al. Gender, age andcircadian blood-pressure variation of apparently healthy rural vs metropolitan Japanese. Chronobiologia 1990; 17(4): 253-65.
9. Sohail S, Yu L, Bennett DA, Buchman AS, Lim ASP. Irregular 24-hour activity rhythms and the metabolic syndrome in older adults. Chronobiol Int 2015; 32(6): 802-13.
10. Weinert D. Age-dependent changes of the circadian system. Chronobiol Int 2000; 17(3): 261-83.
11. Scheer FA, Kalsbeek A, Buijs RM. Cardiovascular control by thesuprachiasmatic nucleus: Neural and neuroendocrine mechanisms in human and rat. Biol Chem 2003; 384(5): 697-709.
12. Arendt J, Skene DJ. Melatonin as a chronobiotic. Sleep Med Rev 2005; 9(1): 25-39.
13. Lemoine P, Wade AG, Katz A, Nir T, Zisapel N. Efficacy andsafety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: A combined analysis of controlled clinical trials. Integr Blood Press Control 2012; 5: 9-17.
14. Lewy AJ, Bauer VK, Hasler BP, Kendall AR, Pires ML, Sack RL.Capturing the circadian rhythms of free-running blind people with0.5 mg melatonin. Brain Res 2001; 918(1-2): 96-100.
15. Lewy AJ, Emens JS, Bernert RA, Lefler BJ. Eventual entrainmentof the human circadian pacemaker by melatonin is independent of the circadian phase of treatment initiation: clinical implications. J Biol Rhythms 2004; 19(1): 68-75.
16. Redfern P, Minors D, Waterhouse J. Circadian rhythms, jet lag, andchronobiotics: An overview. Chronobiol Int 1994; 11(4): 253-65.
17. Sack RL, Lewy AJ. Melatonin as a chronobiotic: Treatment ofcircadian desynchrony in night workers and the blind. J Biol Rhythms 1997; 12(6): 595-603.
18. Touitou Y. Human aging and melatonin. Clinical relevance. ExpGerontol 2001; 36(7): 1083-100.
19. Cajochen C, Krauchi K, Wirz-Justice A. Role of melatonin in theregulation of human circadian rhythms and sleep. J Neuroendocrinol 2003; 15(4): 432-7.
20. Krauchi K. How is the circadian rhythm of core body temperatureregulated? Clin Auton Res 2002; 12(3): 147-9.
21. van Someren EJ. Thermoregulation as a sleep signaling system. Sleep Med Rev 2004; 8(4): 327-8.
22. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: Distribution and functions. Mol Cell Endocrinol 2012; 351(2): 152-66.
23. Govender J, Loos B, Marais E, Engelbrecht AM. Mitochondrialcatastrophe during doxorubicin-induced cardiotoxicity: A review of the protective role of melatonin. J Pineal Res 2014; 57(4): 367-80.
24. Pechanova O, Paulis L, Simko F. Peripheral and central effects ofmelatonin on blood pressure regulation. Int J Mol Sci 2014; 15(10): 17920-37.
25. Obayashi K, Saeki K, Iwamoto J, et al. Nocturnal urinary melatonin excretion is associated with non-dipper pattern in elderly hypertensives. Hypertens Res 2013; 36(8): 736-40.
26. Forman JP, Curhan GC, Schernhammer ES. Urinary melatonin andrisk of incident hypertension among young women. J Hypertens 2010; 28(3): 446-51.
27. Burgess HJ, Sletten T, Savic N, Gilbert SS, Dawson D. Effects ofbright light and melatonin on sleep propensity, temperature, and cardiac activity at night. J Appl Physiol 2001; 91(3): 1214-22.
28. Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GB.Influences of melatonin administration on the circulation of women. Am J Physiol 1998; 274(2 Pt 2): R335-R8.
29. Chuang JI, Chen SS, Lin MT. Melatonin decreases brain serotoninrelease, arterial pressure and heart rate in rats. Pharmacology 1993; 47(2): 91-7.
30. Kitajima T, Kanbayashi T, Saitoh Y, et al. The effects of oral mela-tonin on the autonomic function in healthy subjects. Psychiatry Clin Neurosci 2001; 55(3): 299-300.
31. Sewerynek E. Melatonin and the cardiovascular system. NeuroEndocrinol Lett 2002; 23 (Suppl 1): 79-83.
32. Hardeland R. Melatonin and the theories of aging: a critical ap-praisal of melatonin's role in antiaging mechanisms. J Pineal Res 2013; 55(4): 325-56.
33. Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothe-lial function in humans. Clin Sci (Lond) 2011; 120(9): 357-75.
34. Kunieda T, Minamino T, Miura K, et al. Reduced nitric oxidecauses age-associated impairment of circadian rhythmicity. Circ Res 2008; 102(5): 607-14.
35. Rodella LF, Favero G, Rossini C, et al. Aging and vascular dys-function: Beneficial melatonin effects. Age (Dordr) 2013; 35(1): 103-15.
36. Chang HC, Guarente L. SIRT1 mediates central circadian controlin the SCN by a mechanism that decays with aging. Cell 2013; 153(7): 1448-60.
37. Skene DJ, Swaab DF. Melatonin rhythmicity: Effect of age andAlzheimer's disease. Exp Gerontol 2003; 38(1-2): 199-206.
38. Youngstedt SD, Kripke DF, Elliott JA, Klauber MR. Circadianabnormalities in older adults. J Pineal Res 2001; 31(3): 264-72.
39. Zhao ZY, Xie Y, Fu YR, Bogdan A, Touitou Y. Aging and thecircadian rhythm of melatonin: A cross-sectional study of Chinese subjects 30-110 yr of age. Chronobiol Int 2002; 19(6): 1171-82.
40. Gubin DG, Gubin GD, Waterhouse J, Weinert D. The circadianbody temperature rhythm in the elderly: Effect of single daily melatonin dosing. Chronobiol Int 2006; 23(3): 639-58.
41. Portaluppi F, Smolensky MH, Touitou Y. Ethics and methods forbiological rhythm research on animals and human beings. Chronobiol Int 2010; 27(9-10): 1911-29.
42. Bingham C, Arbogast B, Guillaume GC, Lee JK, Halberg F. Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia 1982; 9(4): 397-439.
43. Gubin DG, Cornelissen G, Weinert D, et al. Circadian disruptionand vascular variability disorders (VVD): Mechanisms linking aging, diseaase state and Arctic shift-work: Applications for chronotherapy. World Heart J 2013; 5(4): 285-306.
44. Carrier J, Monk TH, Reynolds CF III, Buysse DJ, Kupfer DJ. Areage differences in sleep due to phase differences in the output of the circadian timing system? Chronobiol Int 1999; 16(1): 79-91.
45. Reilly T, Waterhouse J, Atkinson G. Aging, rhythms of physicalperformance, and adjustment to changes in the sleep-activity cycle. Occup Environ Med 1997; 54(11): 812-6.
46. Diamant M, Vincent HH. Lisinopril versus enalapril: Evaluation oftrough: Peak ratio by ambulatory blood pressure monitoring. J Hum Hypertens 1999; 13(6): 405-12.
47. Hermida RC, Ayala DE, Fernandez JR, Mojon A, Alonso I, Calvo, C. Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol Int 2002; 19(2): 461-81.
48. Koroboki E, Manios E, Psaltopoulou T, et al. Circadian variation ofblood pressure and heart rate in normotensives, white-coat, masked, treated and untreated hypertensives. Hellenic J Cardiol 2012; 53(6): 432-8.
49. Duffy JF, Dijk DJ. Getting through to circadian oscillators: Whyuse constant routines? J Biol Rhythms 2002; 17(1): 4-13.
50. Waterhouse J, Weinert D, Minors D, et al. A comparison of somedifferent methods for purifying core temperature data from humans. Chronobiol Int 2000; 17(4): 539-66.
51. Kario K, Schwartz JE, Pickering TG. Ambulatory physical activityas a determinant of diurnal blood pressure variation. Hypertension 1999; 34(4 Pt 1): 685-91.
52. Krauchi K, Wirz-Justice A. Circadian rhythm of heat production,heart rate, and skin and core temperature under unmasking conditions in men. Am J Physiol 1994; 267(3 Pt 2): R819-29.
53. Shea SA, Hilton MF, Hu K, Scheer FA. Existence of an endoge-nous circadian blood pressure rhythm in humans that peaks in the evening. Circ Res 2011; 108(8): 980-4.
54. Atkinson G, Witte K, Nold G, Sasse U, Lemmer B. Effects of ageon circadian blood pressure and heart rate rhythms in patients with primary hypertension. Chronobiol Int 1994; 11(1): 35-44.
55. Kawamura H, Ozawa Y, Jumabay M, et al. Time-series analysis ofsystolic blood pressure variation in thirty-three Uygur centenarians in China. Hypertens Res 2003; 26(8): 597-601.
56. Fotherby MD, Potter JF. Twenty-four-hour ambulatory blood pres-sure in old and very old subjects. J Hypertens 1995; 13(12 Pt 2): 1742-6.
57. Kobrin I, Oigman W, Kumar A, et al. Diurnal variation of bloodpressure in elderly patients with essential hypertension. J Am Geriatr Soc 1984; 32(12): 896-9.
58. Ohya Y, Ohtsubo T, Tsuchihashi T, et al. Altered diurnal variationof blood pressure in elderly subjects with decreased activity of daily living and impaired cognitive function. Hypertens Res 2001; 24(6): 655-61.
59. Suzuki Y, Kuwajima I, Aono T, et al. Prognostic value of night-time blood pressure in the elderly: A prospective study of 24-hour blood pressure. Hypertens Res 2000; 23(4): 323-30.
60. Gubin D, Ikonomov O, Stoynev A, Cornelissen G, Halberg F.Human blood pressure chronomes with respect to aging. Nauchny Vestnik Tyum GUBiology 1997; 2: 55-8
61. Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens 2005; 18(12 Pt 1):
62. Grossman E, Laudon M, Zisapel N. Effect of melatonin on noctur-nal blood pressure: Meta-analysis of randomized controlled trials. Vasc Health Risk Manag 2011; 7: 577-84.
63. Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs, RM. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004; 43(2): 1927.
64. Simko F, Bednarova KR, Krajcirovicova K, et al. Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol-induced heart failure. J Pineal Res 2014; 57(2): 177-84.
65. Staessen JA, Wang JG, Thijs L. Cardiovascular protection andblood pressure reduction: A meta-analysis. Lancet 2001; 358(9290): 1305-15.
66. Stoynev AG, Ikonomov OC, Minkova NK, Zacharieva SZ, Stoya-novsky VG. Circadian rhythms of arterial pressure: Basic regulatory mechanisms and clinical value. Acta Physiol Pharmacol Bulg 1999; 24(3): 43-51.
67. Arendt J. Managing jet lag: Some of the problems and possible newsolutions. Sleep Med Rev 2009; 13(4): 249-56.
68. Sack RL. Clinical practice. Jet lag. N Engl J Med 2010; 362(5):440-7.
69. Shimomura K, Lowrey PL, Vitaterna MH, et al. Genetic suppression of the circadian clock mutation by the melatonin biosynthesis pathway. Proc Natl Acad Sci U S A 2010; 107(18): 8399-403.
70. Buhr ED, Yoo SH, Takahashi JS. Temperature as a universal reset-ting cue for mammalian circadian oscillators. Science 2010; 330(6002): 379-85.
71. Farajnia S, Deboer T, Rohling JH, Meijer JH, Michel S. Aging ofthe suprachiasmatic clock. Neuroscientist 2014; 20(1): 44-55.
72. Nakamura TJ, Nakamura W, Yamazaki S, et al. Age-related de-cline in circadian output. J Neurosci 2011; 31(28): 10201-5.
73. de la Sierra A, Redon J, Banegas JR, et al. Prevalence and factorsassociated with circadian blood pressure patterns in hypertensive patients. Hypertension 2009; 53(3): 466-72.